Clinical Trials Directory

Trials / Completed

CompletedNCT02897674

Effect of Palm Olein Intake on Lipid Profile and Fat Deposition

The Chemical Structure of a Lipid Determines Its Effect on Blood Lipid Profile and Fat Deposition

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Aims: To investigate whether diet with realistic doses on palm oil will have an effect on lipid profile and fat deposition in healthy volunteers.

Detailed description

Design: Randomized, parallel design over 14 weeks including a 2 week standardization period and 12 week supplementation. In the standardization period all participants will incorporate palm oil into their diet which will make up 20% of their calories providing a baseline measure. In the supplementation period of 12 weeks, each volunteer will be randomized into one of the three fats: palm olein, interesterified palm olein or soybean oil, consuming 20% of their calories from these fast and remaining 10% fat calories from fats naturally occurring in foods like meat and nuts. Otherwise participants will keep the rest of their diet habitual. Population: 60 healthy males and females aged between 18 and 60 years, of which 30 participants with a BMI between 18.5-24.9kg/m2 and 30 participants with a BMI between 25-29.9kg/m2 and fasting plasma glucose and no evidence of insulin resistance will be recruited. No pre-existing morbidity including cardiac, hepatic or renal disease, history of diabetes, hypertension or hyperlipidemia. Treatment: Pre-intervention: Participants will be asked to record habitual dietary intake by completion of a 4-day food diary and be asked to wear an accelerometer armband to assess physical activity at the beginning and at the end of supplementation period. 2 weeks standardization period: All participants will be asked to replace added fat in their diet with palm olein providing two thirds of 30% fat calories. At the end of the standardization period, which will be the first day of a 12 week dietary intervention, as well as at the end of 12 week supplementation, participants will attend the clinical research facility for a study visit. Weight, height and waist circumference will be taken; total and regional body composition will be measured by MRI. Fasting and post prandial plasma glucose, insulin, appetite hormones and lipids will be measured. Participants will be asked to come in for follow-up visits at week 6 and 10 for a single blood samples and weight check. 12 week supplementation period: participants will be randomized into one of the three supplementation groups: palm olein, interesterified palm olein or soybean oil. Participants will be asked to consume two thirds of their 30%fat calories from one of the oils while incorporating it into their normal diet in cooking and baking.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPalm oleintwo thirds of the 30% fat calories will come from palm olein
DIETARY_SUPPLEMENTInteresterified palm oleintwo thirds of the 30% fat calories will come from interesterified palm olein
DIETARY_SUPPLEMENTsoybean oiltwo thirds of the 30% fat calories will come from soybean oil

Timeline

Start date
2016-02-01
Primary completion
2019-08-01
Completion
2019-08-01
First posted
2016-09-13
Last updated
2019-10-17

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02897674. Inclusion in this directory is not an endorsement.